可除颤心脏收缩力调节装置及其运行方法
By integrating a helical electrode and an MCU processor into the cardiac contractility modulator, timely defibrillation and timing regulation of ventricular fibrillation are achieved, solving the problem that cardiac contractility modulators cannot defibrillate in a timely manner, improving the survival rate of heart failure patients and reducing complications.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHAOXING MAYO XINCI MEDICAL TECH CO LTD
- Filing Date
- 2022-11-11
- Publication Date
- 2026-07-17
AI Technical Summary
Existing cardiac contractility modulators lack defibrillation capabilities and cannot terminate ventricular fibrillation in a timely manner, leading to a high mortality rate among heart failure patients. Furthermore, prolonged cardiac contractility modulation may cause other complications.
Design a defibrillable cardiac contractility modulation device, including a spiral electrode, an MCU processor and a pulse signal generator. The device monitors the electrocardiogram signal by being implanted in the heart and automatically outputs a defibrillation electrical signal when ventricular fibrillation is detected. Combined with a timing device, it controls the regulation of cardiac contractility and defibrillation.
It enables timely defibrillation of ventricular fibrillation, reduces the risk of death for heart failure patients, and reduces the burden on the heart by adjusting the timing, thus preventing complications.
Smart Images
Figure CN115721859B_ABST